NH Korindo Sekuritas Indonesia
Menu
  • Our Service
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
    • Investment Banking
      • IPO
      • E-IPO
    • Download Center
      • Download NAIK
      • Documents
    • Wealth Management
      • Mutual Funds
    • Academy
      • Stock Dictionary
      • Stock Education
  • About Us
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • FAQ
  • Contact
  • Register Now
  • ID
  • EN

Kalbe Farma Tbk (KLBF IJ) Stands to Benefit from State Health Care

  • Author
  • Recent Posts
Putu Chantika
Putu Chantika
Analyst - Consumer, Retail
Putu Chantika
Latest posts by Putu Chantika (see all)
  • ICBP – Supported by Topline Growth - December 20, 2021
  • ACES – Slowdown in 3Q21 Sales - December 7, 2021
  • ERAA – Continue on Growth Path - December 1, 2021

Efficiency: A Key to 2Q19 Rising Earnings
The success in keeping efficiency in check was a boost for KLBF’s sound performance in 2Q19. Its revenues edged up to IDR5.3 trillion (+8.3% y-y or + 9.7% q-q). KLBF, on a cumulative basis, posted revenues of IDR11.2 trillion (+7.6% y-y). EBIT and net profits also surged to IDR858 billion (+14.8% y-y) and IDR663 billion (+5.9% y-y). Of note, the skyrocketing numbers were attributable to declines in the 2Q19 promotion costs to IDR466 billion (-3.6% q-q) and the rupiah stable exchange rates for the US dollar. We project that in FY2019 KLBF likely secures earnings of IDR2.6 trillion or an 8.5% increase (vs. KLBF’s guideline of 6%-8%).

Segmental Highlights
Based on sales breakdown, the distribution & logistics segment was the main contributor (31%) to net sales as the segment posted an 11.6% y-y increase to IDR3.4 trillion. Then, the prescription drugs segment was the second’s biggest contributor (24%) to net sales, with a 7% increase to IDR2.6 trillion (+7.7% y-y). Of note, KLBF’s branded generics dominated the market with the total sales of 51%; licensed products of 28%, and unbranded generics of 21%. Besides, the consumer health and nutritional food segments respectively secured a 5% sales increase to IDR1.9 trillion and IDR 3.1 trillion. To keep their body fit during fasting month and Idulfitri exodus, consumers consumed more nutritional food and supplements, and that became a positive catalyst for the selling of KLBF’s health food and beverages.

 

Download full report HERE.

Share This Article

Related Article


Company Report | Pushing Company’s Online and Offline Channel Performance in 3Q22

21 Dec 2022

In 3Q22, ERAA posted revenue of IDR11.5 trillion, with the Accessories segment leading the growth. 3Q22 gross profit grew by 37.2% YoY to IDR1.1 trillion, amid an increase in the cost of goods sold by 15.6% YoY.

Company Report | Multi-Channel Strategy Improves Company’s Performance in 3Q22

14 Dec 2022

MAPI’s sales were recorded at IDR6.6 trillion in 3Q22 (-0.6% QoQ; +123.1% YoY), and the 9M22 cumulatively grew by 55.8% YoY, supported by the growth of the Sports & Leisure, Fashion, Health & Beauty, Food & Beverage, and Digital Devices segments. As of 3Q22, MAPI has opened 91 new stores.

Company Report | 9M22 Performance Sustained by All Segments in 3Q22

06 Dec 2022

Throughout 9M22, ICBP’s revenue experienced growth, with all segments equally growing, supported by high volumes and average selling prices. However, the high unrealized fx loss from funding activity in 9M22 caused the current period’s profit attributable to owners of the parent entity to contract by 33.4% YoY.

 

More Article

FI Business Trend

03 Feb 2023

The Dollar Falls To A Nine-month Low

The dollar falls to a nine-month low and Treasury yields ease after the Federal Reserve...

READ MORE

Daily Report

03 Feb 2023

Daily Report | 3 February 2023

A gauge of global stocks climbed for a third straight day, the S&P and Nasdaq rallied 1...

READ MORE

FI Business Trend

02 Feb 2023

Federal Reserve Chair Jerome Powell Set A 25 Bp...

Federal Reserve chair Jerome Powell set a 25 bps benchmark rate hike, bringing the FFR ...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Find us facebook twitter instagram youtube

Copyright 2021 NH Korindo Sekuritas. All rights reserved.